FUJIFILM Diosynth Biotechnologies Newsletter – May 2024

FUJIFILM Diosynth Biotechnologies Newsletter – May 2024


Successful Steam Generation in Holly Springs, NC  

We are thrilled to announce that our team in Holly Springs, NC has achieved a significant milestone: we are now officially generating steam! Steam plays an important role in starting up the water systems that supply purified water and water for injection to all the buildings on the site. Steam is one of our most important utilities and brings us one crucial step closer to realizing the potential of our Holly Springs site as part of our global network.  

 

Second Drug Substance Manufacturing Facility in Hillerød Becomes Weathertight    

On April 25th, we celebrated a major achievement in our second expansion project in Hillerød, Denmark, as our second drug substance manufacturing facility became weathertight. This project expands our existing facility by an additional 72,510 square feet and adding eight mammalian cell bioreactors, bringing the total to 20 x 20,000 liters. 



Transforming the Biopharmaceutical Industry: Addressing Patient Access to Medicines with Interconnected Networks 

Within the contract development and manufacturing organization (CDMO) space of biopharmaceuticals, CDMOs have focused on ways to overcome challenges customers face to meet their needs more effectively. Learn more about how we are moving beyond the traditional CDMO transactional business model with our Partners for Life strategy to provide a holistic approach to customers’ entire pipelines, and how our KojoX™ operating philosophy aims to transform the biopharmaceutical industry. 

 

The Perfect Hosts for Vaccine and Virus Expression: Insect Cell Expression Systems 

For over 20 years, we have developed and commercialized multiple insect cell culture projects at various stages of readiness. Our knowledge helps customers to define a strategy to develop, scale-up and manufacture baculovirus expression vector systems (BEVS). Learn more about our solutions that ensure insect cell programs are successful from process development through to commercialization. 

 

De-risking the Development of Tomorrow’s Medicines with Advancing Analytical Characterization Capabilities 

In this webinar, Jason Barker, PhD., Director of Analytical & Formulation Development at FUJIFILM Diosynth Biotechnologies explores the advancements in mass spectrometry, biophysical characterization, automated sample preparation, and high-throughput analytics that are crucial for achieving these goals. 


Upcoming Events 

Booking Now Open for Meetings at BIO 2024 

We're looking forward to attending the BIO 2024 conference in San Diego, CA, from June 3rd to 6th. As we prepare for this prestigious event, we invite you to schedule meetings with us through the BIO One-on-One Partnering app. Let's connect and explore opportunities for collaboration and innovation

To view or add a comment, sign in

Explore topics